A detailed history of Builder Investment Group Inc /Adv transactions in Abbott Laboratories stock. As of the latest transaction made, Builder Investment Group Inc /Adv holds 2,033 shares of ABT stock, worth $237,454. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,033
Previous 2,033 -0.0%
Holding current value
$237,454
Previous $211 Million 9.72%
% of portfolio
0.06%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 22, 2024

BUY
$90.19 - $110.4 $183,356 - $224,443
2,033 New
2,033 $224 Million
Q4 2022

Feb 24, 2023

BUY
$95.06 - $111.52 $193,256 - $226,720
2,033 New
2,033 $223 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Builder Investment Group Inc /Adv Portfolio

Follow Builder Investment Group Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Builder Investment Group Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Builder Investment Group Inc /Adv with notifications on news.